Applications of the Bayesian Prior Information to Evaluation of Equivalence of Similar Biological Medicinal Products

By      

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1254-1263

Taylor & Francis Ltd

Access to resources Recommend Favorite

Prior immunosuppressant use ups Tysabri PML risk

By  

Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Use of Bayesian Methods for Multivariate Bioequivalence Measures

By Souza Roberto   Achcar Jorge Alberto   Martinez Edson Zangiacomi  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 1, 2009-01 ,pp. : 42-66

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evaluation of the Adequacy of Published Studies of Low-Dose Effects of Bisphenol A on the Rodent Prostate for Use in Human Risk Assessment

By Milman H.A.   Bosland M.C.   Walden P.D.   Heinze J.E.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 3, 2002-06 ,pp. : 338-346

Academic Press

Access to resources Recommend Favorite

Distributions of Parameters for Uncertainty Analysis Cannot Be Defined without Using Prior Information

By Boshuizen Hendriek C.  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 392-393

Blackwell Publishing

Access to resources Recommend Favorite